oyster
point
pharma
present
morgan
stanley
virtual
annual
global
healthcare
conference
princeton
globe
newswire
oyster
point
pharma
nasdaq
oyst
biopharmaceutical
company
focused
discovery
development
commercialization
pharmaceutical
therapies
treat
ocular
surface
diseases
today
announced
company
participate
live
q
morgan
stanley
virtual
annual
global
healthcare
conference
friday
september
et
host
investor
meetings
access
live
webcast
please
visit
investors
news
section
oyster
point
pharma
website
https
oyster
point
pharma
oyster
point
pharma
biopharmaceutical
company
focused
discovery
development
commercialization
pharmaceutical
therapies
treat
ocular
surface
diseases
oyster
point
pharma
lead
product
candidate
nasal
spray
highly
selective
cholinergic
agonist
developed
nasal
spray
treat
signs
symptoms
dry
eye
disease
nasal
spray
novel
mechanism
action
tear
film
homeostasis
activating
trigeminal
parasympathetic
pathway
stimulate
glands
cells
responsible
natural
tear
film
production
known
lacrimal
functional
unit
lfu
investor
contact
tim
mccarthy
lifesci
advisors
llc
investors
